Effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on visual discrimination acquisition, performance and reversal in the rat.
Rats received infusions of ibotenic acid into the substantia innominata, in the region of the nucleus basalis of Meynert (nbM), before and after training on simple (simultaneous) and conditional visual discriminations. The ibotenate infusions reduced cortical choline acetyltransferase (ChAT) levels by about 20%, destroyed many ChAT-immunoreactive neurons in the nbM, but also caused the loss of many neurons in the substantia innominata and adjacent areas. These lesions did not impair the acquisition and performance of a simple visual discrimination, but did impair reversal of the discrimination and the performance of a conditional visual discrimination. However, the degree of impairment was unrelated to the degree of cortical ChAT loss. Ibotenic acid lesions to the dorsal globus pallidus also impaired reversal of discrimination but left acquisition and performance unaffected. Striatal dopamine depletion produced by 6-hydroxydopamine (6-OHDA) infusions into the mid-ventral caudate nucleus impaired performance of the simultaneous visual discrimination. Cortical noradrenaline depletion produced by 6-OHDA lesions of the dorsal noradrenergic bundle either alone or in combination with ibotenic acid lesions of the substantia innominata had no effect on acquisition of the discrimination. It is concluded that ibotenic acid lesions of the substantia innominata or to the dorsal globus pallidus affect learning and performance of conditional visual discrimination performance and impair reversal learning without affecting the capacity to discriminate visual events. These results are compared to those following cortical noradrenaline depletion or striatal dopamine loss.
Evenden
J L
JL
Department of Experimental Psychology, University of Cambridge, U.K.
Marston
H M
HM
Jones
G H
GH
Giardini
V
V
Lenard
L
L
Everitt
B J
BJ
Robbins
T W
TW
D000818:Animals; D001288:Attention / Q000502:physiology; D001479:Basal Ganglia / Q000502:physiology*; D001931:Brain Mapping; D002540:Cerebral Cortex / Q000502:physiology; D002795:Choline O-Acetyltransferase / Q000502:physiology; D004193:Discrimination Learning / Q000502:physiology*; D005917:Globus Pallidus / Q000502:physiology*; D008297:Male; D008568:Memory / Q000502:physiology*; D011939:Mental Recall / Q000502:physiology*; D009434:Neural Pathways / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology; D011597:Psychomotor Performance / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D012193:Reversal Learning / Q000502:physiology*; D013377:Substantia Innominata / Q000502:physiology*; D014796:Visual Perception / Q000502:physiology*
D002795:Choline O-Acetyltransferase; D009638:Norepinephrine